Stock MRNA MODERNA, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Other languages Moderna, Inc.

Equities

MRNA

US60770K1079

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-05-13 pm EDT 		After market 04:45:35 pm
125.7 USD +7.13% Intraday chart for Moderna, Inc. 126.3 +0.52%
09:45am Moderna Insider Sold Shares Worth $1,825,220, According to a Recent SEC Filing MT
May. 10 Equities Mostly Rise as Traders Parse Fed Officials' Comments, Consumer Sentiment Survey MT

Other languages

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Compañías que se deben tener muy en cuenta por técnico este lunes en Wall Street
Valores destacados al cierre del mercado norteamericano
Moderna Insider Sold Shares Worth $1,825,220, According to a Recent SEC Filing
Equities Mostly Rise as Traders Parse Fed Officials' Comments, Consumer Sentiment Survey
S&P 500, Dow Rise as Traders Parse Fed Officials' Comments, Consumer Sentiment Survey
Sector Update: Health Care Stocks Higher Late Afternoon
Novavax Surges on $1.2 Billion Sanofi Vaccine Deal
Equity Markets Mixed Intraday After Consumer Sentiment Survey
Sector Update: Health Care Stocks Advance Friday Afternoon
Top Midday Stories: Biden to Reportedly Quadruple Chinese EV Tariffs; Novavax Shares Soar on Sanofi Deal News; Protesters Try to Break Into Tesla's Plant in Germany; FDA Pushes Back Approval of Moderna Vaccine
Moderna : la FDA prend du retard dans l'examen de l'ARNm-1345
Wall Street ouvre en hausse, portée par l'optimisme sur les taux
Sector Update: Health Care Stocks Edge Higher Premarket Friday
Moderna's RSV Vaccine Review Delayed by FDA to End of May
Moderna-La FDA américaine repousse sa décision sur le vaccin contre le VRS
Novavax, Insulet, Moderna... Les valeurs à suivre aujourd'hui à Wall Street
Moderna : la FDA reporte sa décision sur le vaccin anti-VRS
US FDA Delays Approval of Moderna's RSV Vaccine Biologics License Application
US FDA Delays Approval of Moderna's RSV Vaccine Biologics License Application
Moderna Announces Update on Investigational Rsv Vaccine
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. MRNA Stock
  4. News Moderna, Inc.
  5. Other languages
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW